Global pharmaceutical giant Eli Lilly is gearing up to introduce Tirzepatide, its revolutionary weight-loss and diabetes treatment, in India by 2025 under the brand name Mounjaro. “India represents a vibrant market with its large and growing population, increasing health issues related to obesity, diabetes, and cancer, alongside rising health expenditure. This combination fills us with […]